Zhuhe Liu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
ACSL4-mediated astrocyte ferroptosis augments neuroinflammation and exacerbates NMOSD pathology.
Journal: Cell death and differentiation
Published: August 15, 2025
TDP43 augments astrocyte inflammatory activity through mtDNA-cGAS-STING axis in NMOSD.
Journal: Journal of neuroinflammation
Published: October 14, 2024
Harnessing patient-derived antibodies-induced microglial complement 1q expression: Novel therapy for anti-NMDAR encephalitis.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 30, 2024
Mitofusin 2 Mediates the Protective Effect of NR6A1 Silencing Against Neuronal Injury in Experimental Stroke Models.
Journal: Molecular neurobiology
Published: February 17, 2024
IRAK-M suppresses the activation of microglial NLRP3 inflammasome and GSDMD-mediated pyroptosis through inhibiting IRAK1 phosphorylation during experimental autoimmune encephalomyelitis.
Journal: Cell death & disease
Published: August 07, 2022
CXCL7 aggravates the pathological manifestations of neuromyelitis optica spectrum disorder by enhancing the inflammatory infiltration of neutrophils, macrophages and microglia.
Journal: Clinical immunology (Orlando, Fla.)
Published: June 28, 2022
Single-nucleus RNA sequencing unveils critical regulators in various hippocampal neurons for anti-N-methyl-D-aspartate receptor encephalitis.
Journal: Brain pathology (Zurich, Switzerland)
Published: June 27, 2022
Mitofusin 2 confers the suppression of microglial activation by cannabidiol: Insights from in vitro and in vivo models.
Journal: Brain, behavior, and immunity
Published: February 21, 2022
The CSF Levels of Neutrophil-Related Chemokines in Patients with Neuromyelitis Optica.
Journal: Annals of clinical and translational neurology
Published: February 06, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026